Download Free Psychological Treatment Of Patients With Chronic Respiratory Disease Book in PDF and EPUB Free Download. You can read online Psychological Treatment Of Patients With Chronic Respiratory Disease and write the review.

Series foreword -- Acknowledgments -- Introduction -- Understanding the respiratory system and chronic respiratory diseases -- Diagnosis and treatment of pulmonary disease -- Environmental, social, and genetic influences on chronic respiratory disease -- Psychological evaluation of pulmonary patients -- Adjustment -- Anxiety -- Depression -- Tobacco and other inhaled substances -- Family challenges and social support -- End of life -- Ethics and professional issues -- References -- Index -- About the author -- About the series editor.
Chronic diseases are common and costly, yet they are also among the most preventable health problems. Comprehensive and accurate disease surveillance systems are needed to implement successful efforts which will reduce the burden of chronic diseases on the U.S. population. A number of sources of surveillance data-including population surveys, cohort studies, disease registries, administrative health data, and vital statistics-contribute critical information about chronic disease. But no central surveillance system provides the information needed to analyze how chronic disease impacts the U.S. population, to identify public health priorities, or to track the progress of preventive efforts. A Nationwide Framework for Surveillance of Cardiovascular and Chronic Lung Diseases outlines a conceptual framework for building a national chronic disease surveillance system focused primarily on cardiovascular and chronic lung diseases. This system should be capable of providing data on disparities in incidence and prevalence of the diseases by race, ethnicity, socioeconomic status, and geographic region, along with data on disease risk factors, clinical care delivery, and functional health outcomes. This coordinated surveillance system is needed to integrate and expand existing information across the multiple levels of decision making in order to generate actionable, timely knowledge for a range of stakeholders at the local, state or regional, and national levels. The recommendations presented in A Nationwide Framework for Surveillance of Cardiovascular and Chronic Lung Diseases focus on data collection, resource allocation, monitoring activities, and implementation. The report also recommends that systems evolve along with new knowledge about emerging risk factors, advancing technologies, and new understanding of the basis for disease. This report will inform decision-making among federal health agencies, especially the Department of Health and Human Services; public health and clinical practitioners; non-governmental organizations; and policy makers, among others.
In this unique title, the full range of chronic respiratory conditions and their association with psychiatric comorbidities are explored and targeted management options are outlined. Indeed recent studies indicate a far higher prevalence of depression and anxiety in patients afflicted with chronic respiratory conditions than in patients with other chronic disorders. Unlike other publications in the field of pulmonary disease, Depression and Anxiety in Patients with Chronic Respiratory Diseases details this significant correlation. The book is comprehensive in scope, covering such topics as depression and anxiety across the age spectrum, diagnostic tools for anxiety and depression, anxiety and depression in COPD patients, depression and anxiety in adult patients with asthma, and end-stage lung disease and lung transplantation, among others. In this novel work, the volume Editors enlist a team of renowned experts in the fields of respiratory and psychiatric disorders to combine a thorough synthesis of the literature with targeted, practical strategies for management. Depression and Anxiety in Patients with Chronic Respiratory Diseases is an invaluable resource for all clinicians who care for patients with chronic and advanced lung diseases.
Cancer care today often provides state-of-the-science biomedical treatment, but fails to address the psychological and social (psychosocial) problems associated with the illness. This failure can compromise the effectiveness of health care and thereby adversely affect the health of cancer patients. Psychological and social problems created or exacerbated by cancer-including depression and other emotional problems; lack of information or skills needed to manage the illness; lack of transportation or other resources; and disruptions in work, school, and family life-cause additional suffering, weaken adherence to prescribed treatments, and threaten patients' return to health. Today, it is not possible to deliver high-quality cancer care without using existing approaches, tools, and resources to address patients' psychosocial health needs. All patients with cancer and their families should expect and receive cancer care that ensures the provision of appropriate psychosocial health services. Cancer Care for the Whole Patient recommends actions that oncology providers, health policy makers, educators, health insurers, health planners, researchers and research sponsors, and consumer advocates should undertake to ensure that this standard is met.
Chronic Obstructive Pulmonary Disease Exacerbations covers the definition, diagnosis, epidemiology, mechanisms, and treatment associated with COPD exacerbations. This text also addresses imaging and how it plays a pivotal role in the diagnosis and study of exacerbations.Written by today's top experts, Chronic Obstructive Pulmonary Disease Exacerbat
Pulmonary rehabilitation is an effective treatment for people with a range of chronic lung diseases. In recent years, there have been substantial advances in the science underpinning pulmonary rehabilitation. Advances have been seen in the patient groups in whom it is indicated; in the breadth of programme content; in new methods of delivery; and not least, in important outcomes. This Monograph brings together scientific and clinical expertise in pulmonary rehabilitation, with the aim of optimising its delivery in clinical practice.
This book fills a significant research gap in how to integrate quality of life data into relevant clinical care plans, and to broaden its applicability to pharmacoeconomic studies of antipsychotic medications and health policy decision-making. It also presents an argument for reformulating the concept of health-related quality of life in schizophrenia as a bio-psycho-social construct, which provides an opportunity to better explore the many factors underpinning the concept itself. Internationally renowned experts from different scientific backgrounds and scopes of expertise each make arguments for the need to invigorate quality of life as a concept in schizophrenia, by broadening its usefulness for clinical and research efforts. The book represents an important addition to the extensive contributions of its editors, Dr. A. George Awad and Dr. Lakshmi N.P. Voruganti, to the field of quality of life.
This book provides up-to-date knowledge on all aspects of the multidisciplinary approach to pulmonary rehabilitation that is essential in order to achieve optimal results. It will be an ideal resource especially for pulmonologists in training, but will also be of value for physiotherapists, other health care professionals, and technicians. Detailed information is presented on the diverse program components in pulmonary rehabilitation, with clear explanation of the roles of the nutritionist, psychologist, occupational therapist, respiratory nurse, and physical activity coach. Guidance is provided on identification of candidates for pulmonary rehabilitation and on all aspects of assessment, including exercise capacity, muscle function, and physical activity. Patient-centered, economic, and other outcomes are examined, with separate discussion of combined outcome assessment. Furthermore, due consideration is given to organizational aspects of pulmonary rehabilitation and to rehabilitation in specific scenarios, e.g., thoracic oncology and surgery, transplantation, and the ICU. The authors are internationally recognized experts selected for their expertise in the topics they discuss.
Chronic respiratory diseases, such as asthma and chronic obstructive pulmonary disease, kill more than 4 million people every year, and affect hundreds of millions more. These diseases erode the health and well-being of the patients and have a negative impact on families and societies. This report raises awareness of the huge impact of chronic respiratory diseases worldwide, and highlights the risk factors as well as ways to prevent and treat these diseases.